Advertisement
Screener

UFP Technologies, Inc. (UFPT) Net Income (Loss) Available to Common Stockholders, Basic

2.8 / 5 stars · 68/120 Roast Me

UFP Technologies, Inc. Net Income (Loss) Available to Common Stockholders, Basic

UFP Technologies, Inc. (UFPT) reported Net Income (Loss) Available to Common Stockholders, Basic of $16.38 million for the 3-month period ending 2024-12-31, per its 10-K filed 2025-03-03.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2025-03-03

  • UFP Technologies, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2024-12-31 was $16.38M, a 41.08% increase year-over-year.
  • UFP Technologies, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2024-09-30 was $16.36M, a 39.91% increase year-over-year.
  • UFP Technologies, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2024-06-30 was $13.55M, a 14.05% increase year-over-year.
  • UFP Technologies, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2024-03-31 was $12.69M, a 30.33% increase year-over-year.
  • UFP Technologies, Inc. net income (loss) available to common stockholders, basic for fiscal 2013 was $11.28M, a 3.50% increase from fiscal 2012.
  • UFP Technologies, Inc. net income (loss) available to common stockholders, basic for fiscal 2012 was $10.89M, a 5.31% increase from fiscal 2011.
  • UFP Technologies, Inc. net income (loss) available to common stockholders, basic for fiscal 2011 was $10.35M, a 11.88% increase from fiscal 2010.
  • UFP Technologies, Inc. net income (loss) available to common stockholders, basic for fiscal 2010 was $9.25M, a 55.95% increase from fiscal 2009.
Period endNet Income (Loss) Available to Common Stockholders, Basic 3 monthNet Income (Loss) Available to Common Stockholders, Basic 3 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 6 monthNet Income (Loss) Available to Common Stockholders, Basic 6 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 9 monthNet Income (Loss) Available to Common Stockholders, Basic 9 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 12 monthNet Income (Loss) Available to Common Stockholders, Basic 12 month as first filed
2024-12-31$16.38M
10-K · filed 2025-03-03
$32.74M
derived: sum of 2 quarters · filed 2025-03-03
$46.29M
derived: sum of 3 quarters · filed 2025-03-03
$58.98M
derived: sum of 4 quarters · filed 2025-03-03
2024-09-30$16.36M
10-K · filed 2025-03-03
$29.91M
derived: sum of 2 quarters · filed 2025-03-03
$42.61M
derived: sum of 3 quarters · filed 2025-03-03
$54.21M
derived: sum of 4 quarters · filed 2025-03-03
2024-06-30$13.55M
10-K · filed 2025-03-03
$26.25M
derived: sum of 2 quarters · filed 2025-03-03
$37.85M
derived: sum of 3 quarters · filed 2025-03-03
$49.55M
derived: sum of 4 quarters · filed 2025-03-03
2024-03-31$12.69M
10-K · filed 2025-03-03
$24.30M
derived: sum of 2 quarters · filed 2025-03-03
$35.99M
derived: sum of 3 quarters · filed 2025-03-03
$47.88M
derived: sum of 4 quarters · filed 2025-03-03
2023-12-31$11.61M
10-K · filed 2025-03-03
$23.30M
derived: sum of 2 quarters · filed 2025-03-03
$35.18M
derived: sum of 3 quarters · filed 2025-03-03
$44.92M
derived: sum of 4 quarters · filed 2025-03-03
2023-09-30$11.69M
10-K · filed 2025-03-03
$23.58M
derived: sum of 2 quarters · filed 2025-03-03
$33.32M
derived: sum of 3 quarters · filed 2025-03-03
$41.78M
derived: sum of 4 quarters · filed 2025-03-03
2023-06-30$11.88M
10-K · filed 2025-03-03
$21.62M
derived: sum of 2 quarters · filed 2025-03-03
$30.08M
derived: sum of 3 quarters · filed 2025-03-03
$49.62M
derived: sum of 4 quarters · filed 2025-03-03
2023-03-31$9.74M
10-K · filed 2025-03-03
$18.20M
derived: sum of 2 quarters · filed 2025-03-03
$37.74M
derived: sum of 3 quarters · filed 2025-03-03
$46.67M
derived: sum of 4 quarters · filed 2025-03-03
2022-12-31$8.46M
10-K · filed 2025-03-03
$28.00M
derived: sum of 2 quarters · filed 2025-03-03
$36.93M
derived: sum of 3 quarters · filed 2025-03-03
$41.79M
derived: sum of 4 quarters · filed 2025-03-03
2022-09-30$19.54M
10-K · filed 2025-03-03
$28.47M
derived: sum of 2 quarters · filed 2025-03-03
$33.33M
derived: sum of 3 quarters · filed 2025-03-03
$36.55M
derived: sum of 4 quarters · filed 2025-03-03
2022-06-30$8.93M
10-K · filed 2025-03-03
$13.79M
derived: sum of 2 quarters · filed 2025-03-03
$17.01M
derived: sum of 3 quarters · filed 2025-03-03
$20.80M
derived: sum of 4 quarters · filed 2025-03-03
2022-03-31$4.86M
10-K · filed 2025-03-03
$8.08M
derived: sum of 2 quarters · filed 2025-03-03
$11.87M
derived: sum of 3 quarters · filed 2025-03-03
$16.58M
derived: sum of 4 quarters · filed 2025-03-03
2021-12-31$3.22M
10-K · filed 2023-03-16
$7.01M
derived: sum of 2 quarters · filed 2023-03-16
$11.72M
derived: sum of 3 quarters · filed 2023-03-16
$15.89M
derived: sum of 4 quarters · filed 2023-03-16
2021-09-30$3.79M
10-K · filed 2023-03-16
$8.50M
derived: sum of 2 quarters · filed 2023-03-16
$12.67M
derived: sum of 3 quarters · filed 2023-03-16
$16.84M
derived: sum of 4 quarters · filed 2023-03-16
2021-06-30$4.71M
10-K · filed 2023-03-16
$8.88M
derived: sum of 2 quarters · filed 2023-03-16
$13.05M
derived: sum of 3 quarters · filed 2023-03-16
$16.04M
derived: sum of 4 quarters · filed 2023-03-16
2021-03-31$4.16M
10-K · filed 2023-03-16
$8.34M
derived: sum of 2 quarters · filed 2023-03-16
$11.32M
derived: sum of 3 quarters · filed 2023-03-16
$13.64M
derived: sum of 4 quarters · filed 2023-03-16
2020-12-31$4.17M
10-K · filed 2022-03-14
$7.16M
derived: sum of 2 quarters · filed 2022-03-14
$9.48M
derived: sum of 3 quarters · filed 2022-03-14
$13.37M
derived: sum of 4 quarters · filed 2022-03-14
2020-09-30$2.99M
10-K · filed 2022-03-14
$5.31M
derived: sum of 2 quarters · filed 2022-03-14
$9.20M
derived: sum of 3 quarters · filed 2022-03-14
$14.97M
derived: sum of 4 quarters · filed 2022-03-14
2020-06-30$2.32M
10-K · filed 2022-03-14
$6.21M
derived: sum of 2 quarters · filed 2022-03-14
$11.99M
derived: sum of 3 quarters · filed 2022-03-14
$17.63M
derived: sum of 4 quarters · filed 2022-03-14
2020-03-31$3.89M
10-K · filed 2022-03-14
$9.67M
derived: sum of 2 quarters · filed 2022-03-14
$15.31M
derived: sum of 3 quarters · filed 2022-03-14
$19.91M
derived: sum of 4 quarters · filed 2022-03-14
2019-12-31$5.78M
10-K · filed 2021-03-12
$11.42M
derived: sum of 2 quarters · filed 2021-03-12
$16.02M
derived: sum of 3 quarters · filed 2021-03-12
$19.75M
derived: sum of 4 quarters · filed 2021-03-12
2019-09-30$5.64M
10-K · filed 2021-03-12
$10.24M
derived: sum of 2 quarters · filed 2021-03-12
$13.97M
derived: sum of 3 quarters · filed 2021-03-12
$18.38M
derived: sum of 4 quarters · filed 2021-03-12
2019-06-30$4.60M
10-K · filed 2021-03-12
$8.33M
derived: sum of 2 quarters · filed 2021-03-12
$12.74M
derived: sum of 3 quarters · filed 2021-03-12
$16.88M
derived: sum of 4 quarters · filed 2021-03-12
2019-03-31$3.73M
10-K · filed 2021-03-12
$8.14M
derived: sum of 2 quarters · filed 2021-03-12
$12.28M
derived: sum of 3 quarters · filed 2021-03-12
$16.27M
derived: sum of 4 quarters · filed 2021-03-12
2018-12-31$4.41M
10-K · filed 2020-03-13
$8.54M
derived: sum of 2 quarters · filed 2020-03-13
$12.53M
derived: sum of 3 quarters · filed 2020-03-13
$14.31M
derived: sum of 4 quarters · filed 2020-03-13
2018-09-30$4.13M
10-K · filed 2020-03-13
$8.12M
derived: sum of 2 quarters · filed 2020-03-13
$9.90M
derived: sum of 3 quarters · filed 2020-03-13
$12.62M
derived: sum of 4 quarters · filed 2020-03-13
2018-06-30$3.99M
10-K · filed 2020-03-13
$5.77M
derived: sum of 2 quarters · filed 2020-03-13
$8.48M
derived: sum of 3 quarters · filed 2020-03-13
$10.18M
derived: sum of 4 quarters · filed 2020-03-13
2018-03-31$1.78M
10-K · filed 2020-03-13
$4.49M
derived: sum of 2 quarters · filed 2020-03-13
$6.19M
derived: sum of 3 quarters · filed 2020-03-13
$8.82M
derived: sum of 4 quarters · filed 2020-03-13
2017-12-31$2.71M
10-K · filed 2019-03-15
$4.41M
derived: sum of 2 quarters · filed 2019-03-15
$7.04M
derived: sum of 3 quarters · filed 2019-03-15
$9.21M
derived: sum of 4 quarters · filed 2019-03-15
2017-09-30$1.70M
10-K · filed 2019-03-15
$4.33M
derived: sum of 2 quarters · filed 2019-03-15
$6.50M
derived: sum of 3 quarters · filed 2019-03-15
$7.99M
derived: sum of 4 quarters · filed 2019-03-15
2017-06-30$2.63M
10-K · filed 2019-03-15
$4.80M
derived: sum of 2 quarters · filed 2019-03-15
$6.29M
derived: sum of 3 quarters · filed 2019-03-15
$8.96M
derived: sum of 4 quarters · filed 2019-03-15
2017-03-31$2.17M
10-K · filed 2019-03-15
$3.66M
derived: sum of 2 quarters · filed 2019-03-15
$6.33M
derived: sum of 3 quarters · filed 2019-03-15
$9.07M
derived: sum of 4 quarters · filed 2019-03-15
2016-12-31$1.49M
10-K · filed 2018-03-16
$4.16M
derived: sum of 2 quarters · filed 2018-03-16
$6.89M
derived: sum of 3 quarters · filed 2018-03-16
$7.97M
derived: sum of 4 quarters · filed 2018-03-16
2016-09-30$2.67M
10-K · filed 2018-03-16
$5.40M
derived: sum of 2 quarters · filed 2018-03-16
$6.48M
derived: sum of 3 quarters · filed 2018-03-16
$8.15M
derived: sum of 4 quarters · filed 2018-03-16
2016-06-30$2.73M
10-K · filed 2018-03-16
$3.81M
derived: sum of 2 quarters · filed 2018-03-16
$5.49M
derived: sum of 3 quarters · filed 2018-03-16
$7.48M
derived: sum of 4 quarters · filed 2018-03-16
2016-03-31$1.07M
10-K · filed 2018-03-16
$2.75M
derived: sum of 2 quarters · filed 2018-03-16
$4.74M
derived: sum of 3 quarters · filed 2018-03-16
$7.01M
derived: sum of 4 quarters · filed 2018-03-16
2015-12-31$1.68M
10-K · filed 2017-03-10
$3.67M
derived: sum of 2 quarters · filed 2017-03-10
$5.94M
derived: sum of 3 quarters · filed 2017-03-10
$7.59M
derived: sum of 4 quarters · filed 2017-03-10
2015-09-30$1.99M
10-K · filed 2017-03-10
$4.26M
derived: sum of 2 quarters · filed 2017-03-10
$5.92M
derived: sum of 3 quarters · filed 2017-03-10
$7.49M
derived: sum of 4 quarters · filed 2017-03-10
2015-06-30$2.27M
10-K · filed 2017-03-10
$3.93M
10-Q · filed 2015-08-07
$5.50M
derived: sum of 3 quarters · filed 2017-03-10
$7.56M
derived: sum of 4 quarters · filed 2017-03-10
2015-03-31$1.65M
10-K · filed 2017-03-10
$3.22M
derived: sum of 2 quarters · filed 2017-03-10
$5.29M
derived: sum of 3 quarters · filed 2017-03-10
$7.15M
derived: sum of 4 quarters · filed 2017-03-10
2014-12-31$1.57M
10-K · filed 2016-03-11
$3.64M
derived: sum of 2 quarters · filed 2016-03-11
$5.50M
derived: sum of 3 quarters · filed 2016-03-11
$7.56M
derived: sum of 4 quarters · filed 2016-03-11
2014-09-30$2.07M
10-K · filed 2016-03-11
$3.93M
derived: sum of 2 quarters · filed 2016-03-11
$5.99M
10-Q · filed 2014-11-07
$9.37M
derived: sum of 4 quarters · filed 2016-03-11
2014-06-30$1.86M
10-K · filed 2016-03-11
$3.92M
10-Q · filed 2015-08-07
$7.30M
derived: sum of 3 quarters · filed 2016-03-11
$10.19M
derived: sum of 4 quarters · filed 2016-03-11
2014-03-31$2.06M
10-K · filed 2016-03-11
$5.44M
derived: sum of 2 quarters · filed 2016-03-11
$8.33M
derived: sum of 3 quarters · filed 2016-03-11
$11.31M
derived: sum of 4 quarters · filed 2016-03-11
2013-12-31$3.38M
10-K · filed 2015-03-13
$6.26M
derived: sum of 2 quarters · filed 2015-03-13
$9.25M
derived: sum of 3 quarters · filed 2015-03-13
$11.28M
10-K · filed 2014-03-14
2013-09-30$2.89M
10-K · filed 2015-03-13
$2.89M
10-Q · filed 2013-11-07
$5.87M
derived: sum of 2 quarters · filed 2015-03-13
$7.90M
10-Q · filed 2014-11-07
$7.90M
10-Q · filed 2013-11-07
$11.10M
derived: sum of 4 quarters · filed 2015-03-13
2013-06-30$2.98M
10-K · filed 2015-03-13
$2.98M
10-Q · filed 2013-08-08
$5.01M
10-Q · filed 2014-08-08
$5.01M
10-Q · filed 2013-08-08
$8.21M
derived: sum of 3 quarters · filed 2015-03-13
$10.81M
derived: sum of 4 quarters · filed 2015-03-13
2013-03-31$2.03M
10-K · filed 2015-03-13
$2.03M
10-Q · filed 2013-05-10
$5.23M
derived: sum of 2 quarters · filed 2015-03-13
$7.83M
derived: sum of 3 quarters · filed 2015-03-13
$10.58M
derived: sum of 4 quarters · filed 2015-03-13
2012-12-31$3.20M
10-K · filed 2014-03-14
$3.20M
10-K · filed 2013-03-15
$5.80M
derived: sum of 2 quarters · filed 2014-03-14
$8.55M
derived: sum of 3 quarters · filed 2014-03-14
$10.89M
10-K · filed 2014-03-14
$10.90M
10-K · filed 2013-03-15
2012-09-30$2.60M
10-K · filed 2014-03-14
$2.60M
10-Q · filed 2012-11-09
$5.34M
derived: sum of 2 quarters · filed 2014-03-14
$7.69M
10-Q · filed 2013-11-07
$10.70M
derived: sum of 4 quarters · filed 2014-03-14
2012-06-30$2.75M
10-K · filed 2014-03-14
$2.75M
10-Q · filed 2012-08-09
$5.10M
10-Q · filed 2013-08-08
$8.10M
derived: sum of 3 quarters · filed 2014-03-14
$10.54M
derived: sum of 4 quarters · filed 2014-03-14
2012-03-31$2.35M
10-K · filed 2014-03-14
$2.35M
10-Q · filed 2012-05-10
$5.35M
derived: sum of 2 quarters · filed 2014-03-14
$7.79M
derived: sum of 3 quarters · filed 2014-03-14
$10.49M
derived: sum of 4 quarters · filed 2014-03-14
2011-12-31$3.00M
10-K · filed 2013-03-15
$5.44M
derived: sum of 2 quarters · filed 2013-03-15
$8.14M
derived: sum of 3 quarters · filed 2013-03-15
$10.35M
10-K · filed 2014-03-14
$10.35M
10-K · filed 2012-03-15
2011-09-30$2.44M
10-K · filed 2013-03-15
$5.14M
derived: sum of 2 quarters · filed 2013-03-15
$7.34M
10-Q · filed 2012-11-09
$10.43M
derived: sum of 4 quarters · filed 2013-03-15
2011-06-30$2.70M
10-K · filed 2013-03-15
$4.91M
10-Q · filed 2012-08-09
$8.00M
derived: sum of 3 quarters · filed 2013-03-15
$10.36M
derived: sum of 4 quarters · filed 2013-03-15
2011-03-31$2.20M
10-K · filed 2013-03-15
$5.29M
derived: sum of 2 quarters · filed 2013-03-15
$7.66M
derived: sum of 3 quarters · filed 2013-03-15
2010-12-31$3.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15
$5.45M
derived: sum of 2 quarters · filed 2013-03-15
$9.25M
10-K · filed 2013-03-15
2010-09-30$2.36M
10-Q · filed 2011-11-09
$6.16M
10-Q · filed 2011-11-09
2009-12-31$5.93M
10-K · filed 2012-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
NovoCure Ltd (NVCR)$1.886B-11.87
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
AtriCure, Inc. (ATRC)United States$3.089B
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57